BioScrip, Inc.·4/A

Dec 1, 12:18 PM ET

Ordemann Thomas 4/A

4/A · BioScrip, Inc. · Filed Dec 1, 2009

Insider Transaction Report

Form 4/AAmended
Period: 2009-11-11
Ordemann Thomas
Executive Vice President
Transactions
  • Sale

    Common Stock, $.0001 Par Value

    2009-11-11$8.56/sh41,260$353,20220,250 total
Holdings
  • Option To Purchase Common Stock

    Exercise: $2.73From: 2010-04-28Exp: 2019-04-28Common Stock, $.0001 Par Value (75,000 underlying)
    75,000
  • Option To Purchase Common Stock

    Exercise: $5.46From: 2008-08-01Exp: 2017-08-01Common Stock, $.0001 Par Value (80,000 underlying)
    80,000
  • Option To Purchase Common Stock

    Exercise: $6.52From: 2009-04-29Exp: 2018-04-29Common Stock, $.0001 Par Value (50,625 underlying)
    50,625
Footnotes (2)
  • [F1]Shares were sold at various prices between $8.49 and $8.60 per share. The reporting person undertakes to provide (upon request by the SEC staff, the issuer, or a security holder of the issuer) full information regarding the number of shares purchased or sold at each separate price.
  • [F2]Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

Documents

1 file
  • 4
    form4a.xml

    PRIMARY DOCUMENT